EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Boosting the engraftment of subcutaneously transplanted pancreatic islets by nanofat

Selina Wrublewsky, Caroline Bickelmann, Lea Stefanie Meßmer, Cedric Wilden, Charlotte Berhorst, Leticia Prates-Roma, Bruce Morgan, Sandra Rother, Michael D Menger, Matthias W Laschke, Andrea Weinzierl, Emmanuel Ampofo iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Selina Wrublewsky und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Experimental Surgery, Saarland University, PharmaScienceHub (PSH), Homburg, Germany. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Islets of Langerhans, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In the therapy of type 1 diabetes mellitus, the subcutaneous space has been suggested to be a clinically preferable transplantation site for pancreatic islets due to its easy accessibility. However, its poor vascularisation capacity and, thus, challenging environment typically result in islet engraftment failure. In the present proof‐of‐principle study, we demonstrate that this problem can be overcome by nanofat, an emulsified fat derivative already used in clinical practice. Materials and Methods The cellular composition of nanofat was assessed by immunohistochemistry. The angiogenic activity of the soluble and cellular nanofat fraction was analyzed by an angiogenic protein array, tube formation and spheroid sprouting assays. The viability and endocrine function of islets exposed to the nanofat fractions was investigated by flow cytometry, qRT‐PCR and ELISA. In vivo, islets and nanofat were co‐transplanted under the kidney capsule as well as into the subcutaneous space of diabetic animals.

Results

In a panel of in vitro assays, we showed that the soluble and cellular nanofat fraction improve the viability, hormone release, and angiogenic activity of islets. The beneficial effects of these two fractions were validated in vivo in the murine diabetic kidney capsule model, as indicated by an accelerated restoration of normoglycaemia. The co‐transplantation of islets with nanofat resulted in successful islet engraftment within the subcutaneous space of diabetic mice.

Conclusions

These findings demonstrate that nanofat markedly boosts the vascularisation and endocrine function of islet grafts. Hence, its co‐transplantation with pancreatic islets represents a simple, clinically feasible approach to make the subcutaneous space available for future islet transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationIslets of LangerhansDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1AnimalsMiceGraft SurvivalNeovascularization, PhysiologicMaleMice, Inbred C57BLHumansSubcutaneous Tissue

Stichwörter der Autor:innen

diabetesinsulinislet transplantationnanofatvascularization

Autor:innen und Institutionen

  • Institute for Clinical and Experimental Surgery, Saarland University, PharmaScienceHub (PSH), Homburg, Germany.
  • Biophysics Department, Center for Human and Molecular Biology (ZHMB), Saarland University, Homburg, Germany.
  • Institute of Biochemistry, Center for Human and Molecular Biology (ZHMB), Saarland University, Saarbrücken, Germany.
  • Department of Plastic Surgery and Hand Surgery, University Hospital Zurich, Zurich, Switzerland.

ORCID-Profile: Emmanuel Ampofo

Zitieren

APA

Wrublewsky, S., Bickelmann, C., Meßmer, L. S., Wilden, C., Berhorst, C., Prates-Roma, L., Morgan, B., Rother, S., Menger, M. D., Laschke, M. W., Weinzierl, A., & Ampofo, E. (2025). Boosting the engraftment of subcutaneously transplanted pancreatic islets by nanofat. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70127

Vancouver

Wrublewsky S, Bickelmann C, Meßmer LS, Wilden C, Berhorst C, Prates-Roma L, et al. Boosting the engraftment of subcutaneously transplanted pancreatic islets by nanofat. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.70127

BibTeX
@article{Wrublewsky2025,
  author = {Wrublewsky, Selina and Bickelmann, Caroline and Meßmer, Lea Stefanie and Wilden, Cedric and Berhorst, Charlotte and Prates-Roma, Leticia and Morgan, Bruce and Rother, Sandra and Menger, Michael D and Laschke, Matthias W and Weinzierl, Andrea and Ampofo, Emmanuel},
  title = {Boosting the engraftment of subcutaneously transplanted pancreatic islets by nanofat},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.70127}
}
Kostenlos starten →